MILAN — Is chronic lymphocytic leukemia (CLL) progression primarily driven by genetic mutations or by external cues from the tumor microenvironment? Despite major strides in targeted therapies, CLL ...
Early-stage cancer immunotherapy represents a promising yet underexplored frontier in cancer research. While immunotherapeutic strategies have achieved ...
A number of recent trials have explored potential strategies for using immunotherapy in chronic lymphocytic leukemia (CLL). The authors explained that while molecularly targeted therapies like Bruton ...
Over the past decade, the advent of immune checkpoint blockade (ICB) therapy has transformed cancer treatment. Unlike conventional cytotoxic and targeted therapies, immunotherapy leverages both the ...
The tumor microenvironment (TME) market has witnessed substantial growth, with its size projected to expand from $1.54 ...
In the field of neuro-oncology, the dual topics of cellular metabolism and the tumor microenvironment (TME) have gained ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results